SAN FRANCISCO, Sept. 17, 2024 /PRNewswire/ — Sverica Capital Management LP (“Sverica”), a private equity investment firm, announced today that it has made a strategic growth investment in FOUR Inc. (“FOUR” or the “Company”). Founded in 2006, FOUR is a boutique aggregator dedicated to…
Month: September 2024
Upcoming Lead Plaintiff Deadline is November 4, 2024 NEW YORK, Sept. 17, 2024 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) announces that a federal securities class action lawsuit has been filed in the United States District Court for the Central District…
Upcoming Lead Plaintiff Deadline is November 4, 2024 NEW YORK, Sept. 17, 2024 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP (“Wolf Haldenstein”) announces that a federal securities class action lawsuit has been filed in the United States District Court for the Central District…
OSLO, Norway, Sept. 17, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today that international multicenter Phase III clinical trial data for its non-surgical treatment for…
OSLO, Norway, Sept. 17, 2024 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) has communicated today that international multicenter Phase III clinical trial data for its non-surgical treatment for…
Financial services is also most at risk for phishing and brand impersonation CAMBRIDGE, Mass., Sept. 17, 2024 /PRNewswire/ — Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, today released a new State of the Internet (SOTI) report that…
Financial services is also most at risk for phishing and brand impersonation CAMBRIDGE, Mass., Sept. 17, 2024 /PRNewswire/ — Akamai Technologies, Inc. (NASDAQ: AKAM), the cloud company that powers and protects life online, today released a new State of the Internet (SOTI) report that…
The ureteral access sheath market is driven by the rising prevalence of urological disorders, such as kidney stones and ureteral strictures, which necessitate endoscopic procedures. Ureteral access sheaths are used during these procedures to facilitate easy insertion and removal of…
The ureteral access sheath market is driven by the rising prevalence of urological disorders, such as kidney stones and ureteral strictures, which necessitate endoscopic procedures. Ureteral access sheaths are used during these procedures to facilitate easy insertion and removal of…
– ASC30 is the first and only small molecule GLP-1 receptor (GLP-1R) agonist that can be dosed once-monthly subcutaneously and once-daily orally to treat obesity – ASC30 is two- to threefold more potent, in vitro, than orforglipron and stimulated significantly greater insulin secretion…